References
1. Karti SS, Odabasi Z, Korten V, et al. Crimean-Congo hemorrhagic fever
in Turkey. Emerging infectious diseases. 2004;10(8):1379.
2. Leblebicioglu H, Ozaras R, Fletcher TE, Beeching NJ. Crimean-Congo
haemorrhagic fever in travellers: A systematic review. Travel
medicine and infectious disease. 2016;14(2):73-80.
3. Nasirian H. Crimean-Congo hemorrhagic fever (CCHF) seroprevalence: A
systematic review and meta-analysis. Acta tropica.2019;196:102-120.
4. Akıncı E, Bodur H, Leblebicioglu H. Pathogenesis of Crimean-Congo
hemorrhagic fever. Vector-Borne and Zoonotic Diseases.2013;13(7):429-437.
5. Demirtas E, Bakir M, Buyuktuna SA, et al. Comparison of the
Predictive Performance of qSOFA, APACHE2 and SGS for evaluation of the
disease prognosis of CCHF patients at the Emergency Department.Japanese Journal of Infectious Diseases. 2020:JJID. 2019.2507.
6. Mazza BF, Machado FR, Mazza DD, Hassmann V. Evaluation of blood
transfusion effects on mixed venous oxygen saturation and lactate levels
in patients with SIRS/sepsis. Clinics. 2005;60(4):311-316.
7. Goyal M, Pines JM, Drumheller BC, Gaieski DF. Point-of-care testing
at triage decreases time to lactate level in septic patients. The
Journal of emergency medicine. 2010;38(5):578-581.
8. Foushee JA, Hope NH, Grace EE. Applying biomarkers to clinical
practice: a guide for utilizing procalcitonin assays. Journal of
antimicrobial chemotherapy. 2012;67(11):2560-2569.
9. Swanepoel R, Gill D, Shepherd A, Leman P, Mynhardt J, Harvey S. The
clinical pathology of Crimean-Congo hemorrhagic fever. Reviews of
infectious diseases. 1989;11(Supplement_4):S794-S800.
10. Ergönül Ö, Şeref C, Eren Ş, et al. Cytokine response in
Crimean‐Congo hemorrhagic fever virus infection. Journal of
medical virology. 2017;89(10):1707-1713.
11. Kilinc C, Gückan R, Capraz M, et al. Examination of the specific
clinical symptoms and laboratory findings of Crimean-Congo hemorrhagic
fever. Journal of vector borne diseases. 2016;53(2):162.
12. Burt FJ, Swanepoel R, Shieh W-J, Smith JF. Immunohistochemical and
in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in
human tissues and implications for CCHF pathogenesis. Archives of
pathology & laboratory medicine. 1997;121(8):839.
13. Kerget F, Özkurt Z, Öztürk N, Yilmaz S. The relationship with
clinical course and prognosis of serum endothelin-1, angiopoietin-2, and
tie-2 levels in Crimean-Congo hemorrhagic fever. Turkish journal
of medical sciences. 2019;49(4):1192-1197.
14. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B.
Evaluation of serum levels of IL-6, IL-10, and TNF-alpha in patients
with Crimean-Congo hemorrhagic fever. J Infect Dis.
15. Ergönül Ö. Crimean-Congo haemorrhagic fever. The Lancet
infectious diseases. 2006;6(4):203-214.
16. Kerget F, Demirdöğen ŞO, Kerget B. Case Report: A Rare Case of
Crimean–Congo Hemorrhagic Fever Associated with Epididymo-Orchitis.The American Journal of Tropical Medicine and Hygiene.2021:tpmd201143.
17. Luft D, Deichsel G, Schmulling R-M, Stein W, Eggstein M. Definition
of clinically relevant lactic acidosis in patients with internal
diseases. American journal of clinical pathology.1983;80(4):484-489.
18. Kruse O, Grunnet N, Barfod C. Blood lactate as a predictor for
in-hospital mortality in patients admitted acutely to hospital: a
systematic review. Scandinavian journal of trauma, resuscitation
and emergency medicine. 2011;19(1):1-12.
19. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum
procalcitonin and C-reactive protein levels as markers of bacterial
infection: a systematic review and meta-analysis. Clinical
infectious diseases. 2004;39(2):206-217.
20. Gul S, Ozturk DB, Kisa U, Kacmaz B, Yesilyurt M. Procalcitonin
levels and their predictive effect on mortality in Crimean-Congo
Hemorrhagic Fever Patients. Japanese journal of infectious
diseases. 2015:JJID. 2014.2485.